Resveratrol suppresses human cervical carcinoma cell proliferation and elevates apoptosis via the mitochondrial 
and p53 signaling pathways

Li,Lin; Qiu,Rong‑Li; Lin,Yu; Cai,Ying; Bian,Yong; Fan,Yan; Gao,Xiao‑Jun

doi:10.3892/ol.2018.8571

Resveratrol suppresses human cervical carcinoma cell proliferation and elevates apoptosis via the mitochondrial and p53 signaling pathways

Authors:
- Lin Li
- Rong‑Li Qiu
- Yu Lin
- Ying Cai
- Yong Bian
- Yan Fan
- Xiao‑Jun Gao
View Affiliations

Affiliations: Institute of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, P.R. China, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu 210002, P.R. China
Published online on: April 25, 2018 https://doi.org/10.3892/ol.2018.8571
Pages: 9845-9851
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous studies have demonstrated the apoptotic and anti‑proliferative effects of resveratrol, a natural polyphenolic phytoalexin, on various cancer cell lines. However, the effects of resveratrol on the regulation of human cervical carcinoma, and the mechanisms underlying these effects, remain to be elucidated. In the present study, the potential mechanisms underlying the effects of resveratrol in HeLa cervical carcinoma cells were investigated. The results revealed that resveratrol inhibited proliferation and induced apoptosis in HeLa human cervical cancer cells in a dose‑dependent and time‑dependent manner. Resveratrol induced cell shrinkage in HeLa cells and apoptosis accompanied by the activation of caspase‑3 and ‑9. Furthermore, resveratrol upregulated the expression of the pro‑apoptotic B‑cell lymphoma (Bcl)‑2‑associated X protein and downregulated the expression of the anti‑apoptotic proteins Bcl‑2 and Bcl‑extra large in HeLa cells. In addition, p53, a protein that is essential for cell survival and cell cycle progression, exhibited elevated expression levels in resveratrol‑treated HeLa cells. Therefore, resveratrol may be a promising novel inhibitor of human cervical cancer.

View Figures

View References

1	Brisdelli F, D'Andrea G and Bozzi A: Resveratrol: A natural polyphenol with multiple chemopreventive properties. Curr Drug Metab. 10:530–546. 2009. View Article : Google Scholar : PubMed/NCBI
2	Pineda-Sanabria SE, Robertson IM and Sykes BD: Structure of trans-resveratrol in complex with the cardiac regulatory protein troponin C. Biochemistry. 50:1309–1320. 2011. View Article : Google Scholar : PubMed/NCBI
3	Khurana S, Venkataraman K, Hollingsworth A, Piche M and Tai TC: Polyphenols: Benefits to the cardiovascular system in health and in aging. Nutrients. 5:3779–3827. 2013. View Article : Google Scholar : PubMed/NCBI
4	Bollmann F, Art J, Henke J, Schrick K, Besche V, Bros M, Li H, Siuda D, Handler N, Bauer F, et al: Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity. Nucleic Acids Res. 42:12555–12569. 2014. View Article : Google Scholar : PubMed/NCBI
5	Fresco P, Borges F, Diniz C and Marques MP: New insights on the anticancer properties of dietary polyphenols. Med Res Rev. 26:747–766. 2006. View Article : Google Scholar : PubMed/NCBI
6	Singh CK, George SJ and Ahmad N: Resveratrol-based combinatorial strategies for cancer management. Ann N Y Acad Sci. 1290:113–121. 2013. View Article : Google Scholar : PubMed/NCBI
7	De Amicis F, Giordano F, Vivacqua A, Pellegrino M, Panno ML, Tramontano D, Fuqua SA and Andò S: Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J. 25:3695–3707. 2011. View Article : Google Scholar : PubMed/NCBI
8	Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM and Castanas E: Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem. 78:429–441. 2000. View Article : Google Scholar : PubMed/NCBI
9	Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, et al: Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat. 130:387–398. 2011. View Article : Google Scholar : PubMed/NCBI
10	Bae S, Lee EM, Cha HJ, Kim K, Yoon Y, Lee H, Kim J, Kim YJ, Lee HG, Jeung HK, et al: Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol Cells. 32:243–249. 2011. View Article : Google Scholar : PubMed/NCBI
11	Hsieh TC and Wu JM: Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res. 249:109–115. 1999. View Article : Google Scholar : PubMed/NCBI
12	Li G, Rivas P, Bedolla R, Thapa D, Reddick RL, Ghosh R and Kumar AP: Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: Involvement of SIRT1/S6K axis. Cancer Prev Res (Phila). 6:27–39. 2013. View Article : Google Scholar : PubMed/NCBI
13	Torre LA, Bray F, Siege RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
14	Berridge MV, Herst PM and Tan AS: Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. Biotechnol Annu Rev. 11:127–152. 2005. View Article : Google Scholar : PubMed/NCBI
15	Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple mothed for measuring thymocyte apoptosis by propidum iodide staining and flow cytometry. J Immonuol Methods. 139:271–279. 1991. View Article : Google Scholar
16	Khan A, Khan AA, Dwivedi V, Ahmad MG, Hakeem S and Owais M: Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice. Mol Med. 13:266–276. 2007. View Article : Google Scholar : PubMed/NCBI
17	Fang J, Cai C, Wang Q, Lin P, Zhao Z and Cheng F: Systems pharmacology-based discovery of natural products for precision oncology through targeting cancer mutated genes. CPT Pharmacometrics Syst Pharmacol. 6:177–187. 2017. View Article : Google Scholar : PubMed/NCBI
18	Soleas GL, Grass L, Josephy PD, Goldberg DM and Diamandis EP: A comparison of the anticarcinogentic properties of four red wine polyphenols. Clin Biochem. 35:119–124. 2002. View Article : Google Scholar : PubMed/NCBI
19	She QB, Bode AM, Ma WY, Chen NY and Dong Z: Resveratrol-induced activation of P53 and apoptosis is mediated by extracellular-single-regulated protein kinase and P38 kinase. Cancer Res. 61:1604–1610. 2001.PubMed/NCBI
20	Surh YJ, Hurh YJ, Kang JK, Lee E, Kong G and Lee SJ: Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140:1–10. 1999. View Article : Google Scholar : PubMed/NCBI
21	Clément MV, Hirpara JL, Chawdhury SH and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 92:996–1002. 1998.PubMed/NCBI
22	Seeni A, Takahashi S, Takeshita K, Tang M, Sugiura S, Sato SY and Shirai T: Suppression of prostate cancer growth by resveratol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asisan Pac J cancer Prev. 9:7–14. 2008.
23	Liu H, Zang C, Fenner MH, Liu D, Possinger K, Koeffler HP and Elstner E: Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18. Blood. 107:3683–3692. 2006. View Article : Google Scholar : PubMed/NCBI
24	Roy P, Kalra N, Prasad S, George J and Shukla Y: Chemopreventive potential of Resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res. 26:211–217. 2009. View Article : Google Scholar : PubMed/NCBI
25	Kidd VJ: Proteolytic activities that mediate apoptosis. Annu Rev Physiol. 60:533–573. 1998. View Article : Google Scholar : PubMed/NCBI
26	Kurokawa M and Kornbluth S: Caspases and kinases in a death grip. Cell. 138:838–854. 2009. View Article : Google Scholar : PubMed/NCBI
27	Kook S, Zhan X, Cleghorn WM, Benovic JL, Gurevich VV and Gurevich EV: Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death. Cell Death Differ. 21:172–184. 2014. View Article : Google Scholar : PubMed/NCBI
28	Xiong S, Mu T, Wang G and Jiang X: Mitochondria-mediated apoptosis in mammals. Protein Cell. 5:737–749. 2014. View Article : Google Scholar : PubMed/NCBI
29	Liu J, Li Y, Ren W and Hu WX: Apoptosis of HL-60 cells induced by extracts from Narcissus tazetta var. chinensis. Cancer Lett. 242:133–140. 2006. View Article : Google Scholar : PubMed/NCBI
30	Hiraoka D, Aono R, Hanada S, Okumura E and Kishimoto T: Two new competing pathways establish the threshold for cyclin-B-Cdk1 activation at the meiotic G2/M transition. J Cell Sci. 129:3153–3166. 2016.PubMed/NCBI
31	Pal HC, Sharma S, Elmets CA, Athar M and Afaq F: Fisetin inhibits growth, induces G₂/M arrest and apoptosis of human epidermoid carcinoma A431 cells: Role of mitochondrial membrane potential disruption and consequent caspases activation. Exp Dermatol. 22:470–475. 2013. View Article : Google Scholar : PubMed/NCBI
32	Bhattacharya S, Ray RM and Johnson LR: Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells. Apoptosis. 19:451–466. 2014. View Article : Google Scholar : PubMed/NCBI
33	Zhang Z, Wang CZ, Du GJ, Qi LW, Calway T, He TC, Du W and Yuan CS: Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol. 43:289–296. 2013. View Article : Google Scholar : PubMed/NCBI
34	Charrier-Savournin FB, Château MT, Gire V, Sedivy J, Piette J and Dulic V: p21-mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell. 15:3965–3976. 2004. View Article : Google Scholar : PubMed/NCBI
35	Chae SW, Sohn JH, Kim DH, Choi YJ, Park YL, Kim K, Cho YH, Pyo JS and Kim JH: Overexpressions of cyclin B1, cdc2, p16 and p53 in human breast cancer: The clinicopathologic correlations and prognostic implications. Yonsei Med J. 52:445–453. 2011. View Article : Google Scholar : PubMed/NCBI